Emerging concepts in preeclampsia investigation

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Pathophysiology

Background:

• Preeclampsia is a pregnancy-specific disorder with significant short- and long-term health implications for both mother and fetus.
• Its pathophysiology is characterized by two main stages: reduced placental perfusion (Stage 1) and the maternal clinical syndrome (Stage 2).
• Stage 1 involves complex processes affecting trophoblast invasion and placental function, leading to Stage 2 in susceptible individuals.

Purpose of the Study:

• To provide a comprehensive overview of the emerging understanding of preeclampsia pathophysiology.
• To detail the factors contributing to the two stages of preeclampsia.
• To highlight the ongoing research aimed at translating this knowledge into clinical applications.

Main Methods:

• This chapter introduces the pathophysiologic framework of preeclampsia.
• It outlines the key processes involved in reduced placental perfusion.
• It describes the convergence of inflammatory, metabolic, and thrombotic responses in the maternal syndrome.

Main Results:

• Emerging research reveals a multi-faceted understanding of preeclampsia's underlying mechanisms.
• Reduced placental perfusion is a critical initiating factor.
• Maternal responses involve systemic inflammation, metabolic alterations, and thrombotic events impacting vascular health.

Conclusions:

• A comprehensive understanding of preeclampsia's two-stage pathophysiology is crucial.
• Continued research is essential for developing effective preventive and therapeutic strategies.
• Translating scientific insights into clinical practice remains the primary objective for preeclampsia research.